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Epiblast cells in the early post-implantation stage
mammalian embryo undergo a transition described
as lineage priming before cell fate allocation, but
signaling pathways acting upstream remain ill
defined. Genetic studies demonstrate that Smad2/3
double-mutant mouse embryos die shortly after
implantation. To learn more about the molecular dis-
turbances underlying this abrupt failure, here we
characterized Smad2/3-deficient embryonic stem
cells (ESCs). We found that Smad2/3 double-
knockout ESCs induced to form epiblast-like cells
(EpiLCs) display changes in naive and primed plurip-
otency marker gene expression, associated with the
disruption of Oct4-bound distal regulatory elements.
In the absence of Smad2/3, we observed enhanced
Bmp target gene expression and de-repression
of extra-embryonic gene expression. Cell fate alloca-
tion into all three embryonic germ layers is disrupted.
Collectively, these experiments demonstrate that
combinatorial Smad2/3 functional activities are
required to maintain distinct embryonic and/or
extra-embryonic cell identity during lineage priming
in the epiblast before gastrulation.INTRODUCTION
The strict segregation of embryonic and extra-embryonic tissues
constitutes the earliest cell fate decision in the pre-implantation
mammalian embryo. Later, during gastrulation through coordi-
nated patterning by Nodal and Bmp signaling, pluripotent
epiblast cells are induced to form the three primary germ layers:
mesoderm, definitive endoderm (DE), and ectoderm (Robertson,
2014). However, studies demonstrate that epiblast cells acquire
competence to differentiate in response to inductive signaling
cues at earlier stages (Smith, 2017). This cellular transition,
designated as lineage priming or epiblast maturation and char-
acterized in cultured epiblast-like cells (EpiLCs) (Buecker et al.,
2014; Hayashi et al., 2011), is associated with genome-wideCell Re
This is an open access article undreorganization of active enhancers, resulting in decreased
expression of naive pluripotency genes, activation of primed
and early differentiation genes, and importantly, stable repres-
sion of extra-embryonic gene expression (Morgani et al., 2017;
Murakami et al., 2016). However, relatively little is known about
the underlying molecular mechanisms driving these cellular
events.
Our early work showed that Nodal, amember of the transform-
ing growth factor b (TGF-b) superfamily of secreted growth fac-
tors, is required for axis patterning in the early post-implantation
stage embryo (Brennan et al., 2001). Loss-of-function embryos
arrest before gastrulation, fail to form mesoderm, prematurely
lose expression of pluripotency markers, and precociously acti-
vate neuroectodermmarkers (Brennan et al., 2001; Camus et al.,
2006; Mesnard et al., 2006). Nodal receptors activate the closely
related downstream intracellular effectors Smad2 and Smad3
(Smad2/3) that translocate into the nucleus to regulate target
gene expression (Massague´, 2012). Smad2/3 share >90%
amino acid identity and display partially overlapping expression
patterns in the early embryo (Dunn et al., 2004; Waldrip et al.,
1998). However, loss-of-function mutants display strikingly
different phenotypes. Animals lacking Smad3 are adult viable
(Datto et al., 1999). In contrast, Smad2 mutant embryos fail to
acquire anterior-posterior patterning and arrest shortly after im-
plantation (Waldrip et al., 1998). Instead, because of loss of
Smad2 in the extra-embryonic primitive endoderm (where
Smad3 is not expressed), the epiblast defaults exclusively to
an extra-embryonic mesodermal fate (Dunn et al., 2004; Waldrip
et al., 1998). Smad3 expression from the Smad2 locus can
rescue the lethal phenotype (Dunn et al., 2005). Moreover,
Smad2/3 clearly function in a dose-dependent manner (Vincent
et al., 2003). Thus, double-mutant embryos lacking both
Smad2/3 abruptly arrest shortly after implantation and are
severely disorganized (Dunn et al., 2004).
Previous efforts aimed at dissecting partially overlapping
Smad2/3 functional contributions have been hampered by
this early lethality. Here we exploited embryonic stem
cells (ESCs) lacking both Smad2/3, in combination with
directed in vitro differentiation protocols, to gain insight into
the underlying defects. We observe that Smad2/3 double-
mutant ESCs fail to undergo lineage priming or correct cell
fate allocation and ectopically activate extra-embryonic
genes. This priming defect was associated with inappropriateports 24, 1977–1985, August 21, 2018 ª 2018 The Author(s). 1977
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Smad2/3 Repress Expression of
Extra-Embryonic and Naive Pluripotency
Genes during Lineage Priming
(A) WT, Smad2 KO, Smad3 KO, or Smad2/3 DKO
ESCs (2iL) were stained for Oct4 and Nanog and
counterstained with DAPI.
(B) Venn diagrams showing significant changes in
gene expression shared by Smad2 KO, Smad3
KO, and Smad2/3 DKOESCs, relative toWT ESCs,
as determined by microarray profiling (n = 3 or 4).
Genes uniquely differentially expressed by Smad2
KO or Smad3 KO ESCs were excluded from this
analysis. A summary of deregulated genes is pre-
sented in Table S1.
(C) Pie charts of alkaline phosphatase (AP)-stained
WT, Smad2 KO, Smad3 KO, or Smad2/3 DKO
ESCs cultured for 5 days in the presence or
absence of LIF (n = 3), corresponding to pluripo-
tent, differentiated, or mixed colonies. See also
Figure S1F.
(D) Scatterplot showing significantly (p < 0.05,
Benjamini-Hochberg adjusted) differentially
expressed genes in Smad2/3 DKO EpiLCs
compared to WT by RNA-seq (n = 3). The cutoff
was set to >1.5-fold change. Differentially
expressed genes near Smad2/3 ChIP-seq peaks
in day 3 EBs (%50 kb of its transcriptional start
site [TSS]) are indicated in yellow. The pie
chart indicates the proportion of differentially ex-
pressed genes also showing Smad2/3 ChIP-seq
peaks (%50 kb of TSS).
(E) Heatmap showing relative expression levels of
pluripotencymarker genes in Smad2/3 DKOESCs,
EpiLCs, and day 3 EBs compared to WT controls
(n = 3 or 4). Profiles of Smad2 KO and Smad3 KO
day 3 EBs are shown on the right.activation of Oct4-bound distal regulatory sites and enhanced
Bmp target gene expression. Collectively, the present results
demonstrate that combinatorial Smad2/3 activities are required
to maintain embryonic identity in the early epiblast during line-
age priming.
RESULTS
Smad2/3 Inactivation in ESCs Fails to Disrupt Self-
Renewal and Expression of Pluripotency Marker Genes
To investigate functional contributions made by the closely
related Smad2/3 transcriptional regulators, we targeted the
Smad3 promoter in Smad2/ (Smad2 knockout [KO]) (Trem-
blay et al., 2000) or wild-type (WT) ESCs to generate
Smad2/;Smad3/ ESCs (Smad2/3 double knockout
[DKO]) and Smad3/ ESCs (Smad3 KO) (Figure S1A).
Correctly targeted clones were identified by Southern blot
analysis, and loss of Smad3 protein expression was
confirmed by western blotting (Figures S1B and S1C). WT,
Smad2 KO, Smad3 KO, and Smad2/3 DKO ESCs cultured
under 2i + LIF (2iL) or serum + LIF (SL) conditions were
morphologically indistinguishable (Figure S1D). Smad2/3
DKO ESCs efficiently formed colonies and displayed
robust Oct4 and Nanog expression levels (Figures 1A, S1D,
and S1E).1978 Cell Reports 24, 1977–1985, August 21, 2018To examine gene expression changes, we carried out tran-
scriptional profiling experiments using microarrays. We identi-
fied 422 genes with significantly changed expression levels
(209 down and 213 up) in Smad2/3 DKO ESCs cultured under
SL conditions compared to WT ESCs (Figure 1B; Table S1).
Several Nodal targets (Lefty1/2 and Pitx2) were downregulated,
while Bmp target genes (Id1/2/3) were upregulated. Genes nor-
mally confined to trophectoderm derivatives (Tle3, Plac1, Pparg,
and Prl2c3) and extra-embryonic primitive endoderm (Pdgfra
and Sox7) were upregulated in Smad2/3 DKO ESCs. A subset
of differentially expressed genes was also significantly altered
in either Smad2 KO or Smad3 KO ESCs (33% and 12%, respec-
tively) (Figure 1B). Smad2, but not Smad3, KO ESCs display up-
regulated extra-embryonic gene expression. There was no evi-
dence for altered expression of pluripotency markers (Table S1).
Loss of Smad2/3 Results in Activation of Extra-
Embryonic and Bmp Target Gene Expression upon Exit
from the Undifferentiated State
To test whether these transcriptional changes potentially influ-
ence exit from the naive state, we induced differentiation by
plating ESCs (SL) at low density in the absence of LIF and
performed alkaline phosphatase (AP) staining to identify naive
ESCs. Similar to WT or single-KO ESCs, Smad2/3 DKO
ESCs gave rise to AP-negative colonies (Figure 1C). As for
BMP4-treatedWTESCs that similarly exhibit a bias toward extra-
embryonic gene expression, Smad2/3DKOand to a lesser extent
Smad2 KO ESC colonies displayed a distinctive, more flattened,
epithelial morphology (Hayashi et al., 2010) (Figure S1F).
To further explore exit from the naive state, we compared gene
expression profiles of WT and Smad2/3 DKO EpiLCs using RNA
sequencing (RNA-seq). As expected, WT ESCs (2iL) induced to
form EpiLCs by activin A and Fgf2 treatment adopted a flattened
cell morphology. The appearance of Smad2/3 DKO EpiLCs
closely resembled WT (Figure S1G). RNA-seq analysis identified
2,098 genes with significantly changed expression in Smad2/3
DKO compared to WT EpiLCs (1,100 down and 998 up) (Fig-
ure 1D; Table S2). We found that expression levels of Nodal-
dependent genes (e.g., Lefty1/2 and Pitx2) and early mesoderm
markers (e.g., T and Fgf8) were downregulated in Smad2/3 DKO
EpiLCs. However, Bmp targets (e.g., Id1/2/3/4) and extra-em-
bryonic ectoderm (e.g., Fgfr2 and Tfap2c), trophectoderm
(e.g., Gata2 and Gata3), and visceral endoderm (VE) (e.g., H19
and Sparc) marker genes were activated.
Next, we compared the list of differentially expressed
genes with published Smad2/3 chromatin immunoprecipitation
sequencing (ChIP-seq) datasets (Wang et al., 2017). We found
that 18% of differentially expressed genes in Smad2/3 DKO
EpiLCs were occupied by Smad2/3 in differentiated embryoid
bodies (EBs), in contrast to only 3% in ESCs (Table S2).
Smad2/3-occupied differentially expressed genes included
both Nodal and Bmp targets. Except for Fgfr2 and Tfap2c (en-
coding Ap2g) none of the ectopically activated extra-embryonic
genes were found to be Smad2/3 occupied, which implicates an
indirect regulatory mechanism, assuming Smad2/3 occupancy
is similar between EpiLCs and EBs.
Combinatorial Smad2/3 Activities Control Pluripotency-
Associated Gene Expression during Lineage Priming
Smad2/3 DKO EpiLCs display enhanced expression of naive
pluripotency markers (e.g., Klf2 and Rex1) characteristic of the
blastocyst inner cell mass, together with decreased expression
of primed pluripotency markers (e.g., Fgf5 andOct6) (Figure 1E).
Reduced Oct6 expression was confirmed by immunofluores-
cence staining experiments (Figure S1G). In contrast, expression
of the epiblast marker Otx2 was unchanged (Figures 1E and
S1G). To further examine gene expression changes during differ-
entiation, Smad2/3 DKO ESCs were induced to form EBs and
transcriptional profiles were analyzed using microarrays. As
shown in Figure 1E, Smad2/3 DKO EBs display striking downre-
gulation of primed pluripotency markers and upregulated
expression of naive pluripotency genes. In addition, when we
analyzed single-KO EBs, we found that Smad2 KO EBs, but
not Smad3 KO EBs, resembled Smad2/3 DKO EBs. Consistent
with this, EpiLCs express Smad2 at roughly 5-fold higher levels
in comparison with Smad3. Thus, Smad2 activity is predomi-
nantly responsible for governing the gain of primed and/or differ-
entiated identity during lineage priming.
Smad2/3 Influence Chromatin Accessibility during the
ESC-to-EpiLC Transition
The preceding results demonstrate that Smad2/3 activities
regulate pluripotency-associated gene expression. However,we detected a relatively low degree of overlap between
Smad2/3-dependent transcripts and nearby sites of Smad2/3
binding using published Smad2/3 ChIP-seq datasets from
day 3 EBs (Wang et al., 2017). These experimental approaches
provided only a limited view of the Smad2/3 regulatory
network. Global changes in the activities of distal regulatory
elements, such as enhancers, during acquisition of the primed
state have been previously documented (Buecker et al., 2014;
Factor et al., 2014). Therefore, we decided to evaluate possible
changes affecting the distal regulatory element landscape in
Smad2/3 DKO EpiLCs using the assay for transposase acces-
sible chromatin (ATAC)-seq.
We identified 4,274 regulatory elements that were differentially
accessible in Smad2/3 DKO compared to WT EpiLCs (3,234
decreased and 1,040 increased) (Figure 2A; Table S3). To
explore the possibility that Smad2/3-dependent regulatory ele-
ments potentially influence the transition to the primed state,
we identified sites where chromatin accessibility is changed dur-
ing the ESC-to-EpiLC transition by comparing EpiLC ATAC-seq
data with our publishedWTESCATAC-seq dataset (Simon et al.,
2017). Most (90%) Smad2/3-dependent sites undergo changes
in chromatin accessibility during the ESC-to-EpiLC transition
(Figure 2B). Furthermore, many of these were located more
than 5 kb from transcriptional start sites (Figure 2C) and
displayed an enrichment for markers of distal regulatory
elements, including p300, H3K27ac, and H3K4me1 (Figure 2D).
These observations suggest that combinatorial Smad2/3 activ-
ities influence the global reconfiguration of the chromatin land-
scape during lineage priming.
Changes in chromatin accessibility at distal regulatory ele-
ments in Smad2/3 DKO EpiLCs potentially influence expression
of nearby genes. To test this possibility, we compared ATAC-seq
and transcriptional profiles. We found that sites with decreased
accessibility were associated with reduced expression of nearby
genes (Figure 2E). For example, Lefty1/2 and Pitx2 display
decreased chromatin accessibility at nearby enhancer regions
normally occupied by Smad2/3 during differentiation (Figures
2F, 2G, and S2A). In contrast, sites that displayed increased
chromatin accessibility were associated with increased expres-
sion levels (Figure 2E); however, unlike sites showing decreased
accessibility, these loci tended to have lower levels of Smad2/3
binding (Figure 2G). Sites of increased accessibility are associ-
ated with increased Smad1 occupancy in BMP4-treated ESCs
(Morikawa et al., 2016) (Figure 2G). Collectively, these results
demonstrate that Smad2/3 act to promote full access to distal
regulatory elements governing gene expression changes neces-
sary for cells to transition to the primed state.
Oct4 and Otx2 Occupy Smad2/3-Dependent Distal
Regulatory Elements
Studies demonstrate that Oct4 binding switches from naive en-
hancers to primed enhancers at pluripotency genes coincident
with occupancy by so-called mediators of the primed state,
such as Otx2, during the ESC-to-EpiLC transition (Buecker
et al., 2014). Here we observe in EpiLCs an enrichment of
Oct4 and Otx2 ChIP-seq signals at Smad2/3-dependent sites
that display decreased chromatin accessibility (Figures 2F
and 2G). Motif enrichment analysis confirmed these sites areCell Reports 24, 1977–1985, August 21, 2018 1979
Figure 2. Smad2/3 Influences the Activity of
Oct4-Occupied Distal Regulatory En-
hancers during Priming
(A) Heatmap of regulatory elements with differen-
tial chromatin accessibility in Smad2/3 DKO
EpiLCs compared to WT EpiLCs, as measured by
ATAC-seq (false discovery rate [FDR] < 0.05, fold
change > 1.5). Sites with decreased chromatin
accessibility (top) and sites with increased
chromatin accessibility (bottom) are ranked by
decreasing and increasing ATAC signal change.
See also Table S3.
(B and C) Pie charts indicating (B) distributions of
differential accessible sites in Smad2/3 DKO
EpiLCs compared to WT overlapping with regula-
tory elements gained or lost during the ESC-to-
EpiLC transition or (C) the distance to known TSS
as defined by Genomic Regions Enrichment of
Annotations Tool (GREAT).
(D) Heatmap read density plots of p300, H3K27ac,
and H3K4me1 ChIP-seq signal at regulatory ele-
ments with differential accessibility in Smad2/3
DKO EpiLCs (ranked as in A).
(E) Heatmap depicting the log2 fold change
(log2FC) in gene expression in Smad2/3 DKO
EpiLCs relative to WT EpiLCs as determined by
RNA-seq. Genes nearest regulatory elements with
differential accessibility in Smad2/3 DKO EpiLCs
are shown.
(F) Genome browser snapshots of RNA-seq and
ATAC-seq tracks in Smad2/3 DKO andWT EpiLCs
at selected genomic loci. ATAC-seq of WT ESCs,
ChIP-seq tracks of Smad2/3 occupancy in ESCs
and day 3 EBs, and Oct4 and Otx2 occupancy in
EpiLCs are also shown.
(G) Heatmap read density plots of WT Smad2/3,
Smad1, Oct4, and Otx2 ChIP-seq signal in the
indicated cell types at regulatory elements with
differential accessibility in Smad2/3 DKO EpiLCs
(ranked as in A). ESCs were treated with 10 ng/mL
BMP4 for Smad1 ChIP-seq.
(H) Motif enrichment analysis of regulatory ele-
ments with differential chromatin accessibility in
Smad2/3 DKO EpiLCs. Motifs for transcription
factors associated with primed or naive, extra-
embryonic, and neural cell states were significantly
enriched.highly enriched for Oct4 and Otx2 binding motifs and those
recognized by other priming factors, e.g., Oct6 and Foxd3 (Fig-
ure 2H). Fgf5, Oct6, and Foxa2, genes characteristic of the
primed state, display decreased accessibility (Figures 2F and
S2B). In contrast, in the absence of Smad2/3, Klf2, an Oct4/
Otx2-occupied gene that characterizes the naive state, shows
increased accessibility at a neighboring distal regulatory
element and increased expression levels (Figure 2F). These
genomic regions were also enriched for naive, extra-embry-
onic, and neural transcription factor binding motifs (Figure 2H).
However, accessibility near early differentiation and extra-
embryonic marker genes appeared to be largely unaffected
(Figures S2C and S2D). These observations strengthen the1980 Cell Reports 24, 1977–1985, August 21, 2018argument that cooperative binding by different transcription
factors is required during lineage priming and demonstrate
that Smad2/3, together with the pioneer factor Oct4 (Mullen
et al., 2011; Ruetz et al., 2017), targets distal regulatory
elements controlling the transition from the naive to the primed
state.
Loss of Smad2/3 Disrupts Cell Fate Allocation during
ESC Differentiation
To investigate downstream consequences resulting from this
priming defect, we re-examined the Smad2/3 DKO EB microar-
ray profiles. We identified 3,104 genes showing significantly
changed expression levels in Smad2/3 DKO compared to WT
Figure 3. Smad2/3 Governs Embryonic Cell
Fate Specification
(A) Heatmap showing the log2 fold change
(log2FC) in expression of the top 20 genes upre-
gulated in day 3 WT EBs relative to WT ESCs (left)
in comparison with their expression changes in
Smad2/3 DKO (right). See also Table S1.
(B) Anti-AP2g and Oct4 immunofluorescence
staining of WT and Smad2/3 DKO day 2 and 4
PGCLCs.
(C) WT and Smad2/3 DKO NPCs at day 7 stained
with anti-Tuj1 and counterstained with DAPI.
(D) Bright-field images of control WT or Smad2/3
DKO NPCs grown in the absence or presence of
BMP4 (5 ng/mL) at days 3, 5, and 7.
(E) WT and Smad2/3 DKO NPCs grown in the
absence or presence of BMP4 (5 ng/mL) stained
with anti-Sox1 and Ap2g and counterstained with
DAPI at day 5.day 3 EBs (1,487 down and 1,617 up) (Figure S3A). Expression of
the top 20 genes normally activated during differentiation was
dramatically reduced in Smad2/3 DKO EBs (Figure 3A). Expres-
sion of several mesodermal (Wnt3, T, Fgf8, Mixl1, Sp8, Eomes,
Mesp1, and Lhx1) and DE lineage marker genes (Foxa2,
Sox17, Cxcr4, and Gata6), including a subset known to be direct
targets of Smad2/3 in EBs (Wang et al., 2017), were significantly
downregulated (Table S1). Profiling at an earlier point revealed
that expression of a subset of differentiation genes (e.g., T,
Cdx2, Wnt8a, and Sp5) was initially induced in Smad2/3 DKO
day 2 EBs but failed to be maintained. These transcriptional
changes were validated for selected genes by immunofluores-
cent staining (Figure S3B). Experiments analyzing single-KO
EBs demonstrate that both Smad2/3 contribute to expression
changes (Figures S3A and S3C). When differentially expressedCell Repgenes in Smad2/3 DKO day 3 EBs were
assessed for their relative expression
changes in Smad2/3 DKO EpiLCs and
ESCs, we found that Smad2/3 is essential
for correct gene expression patterns dur-
ing differentiation at early stages as cells
enter the primed state (Figure S3D).
Primordial germ cells (PGCs) are spec-
ified in the early epiblast in response to
Bmp signaling from the extra-embryonic
ectoderm. To test whether PGC specifi-
cation is affected by loss of Smad2/3,
we exploited PGC-like cell (PGCLC)
differentiation protocols (Hayashi and
Saitou, 2013). AP2g/Oct4 co-expression
identifies PGCs in the early embryo.
In WT cultures, Oct4/AP2g double-posi-
tive cells were readily apparent at day 2
and abundant numbers were present at
day 4, but by contrast, day 2 and 4
Smad2/3 DKO cultures contained pre-
dominantly Oct4 and AP2g single-posi-
tive cells (Figure 3B), allowing us toconclude that their ability to acquire PGC-like fates is also
compromised.
Smad2/3 Governs the Balance of Nodal/Bmp Signaling
during Ectoderm Specification
To evaluate whether ectodermal cell fate decisions are also
Smad2/3 dependent, we exploited culture protocols that pro-
mote neuroectodermal precursor cell (NPC) formation. Tuj1+
staining identified a subpopulation of bona fide elongated neu-
ral cells in day 7 Smad2/3 DKO cultures (Figure 3C). However,
as for BMP4-treated WT NPCs (Malaguti et al., 2013), from
day 3 onward, most cells displayed a flattened epithelial, sur-
face-ectoderm-like morphology (Figure 3D). At day 5, a high
proportion of WT cells expresses the early neural marker
Sox1. BMP4 treatment normally represses Sox1 expression inorts 24, 1977–1985, August 21, 2018 1981
Figure 4. Enhanced Bmp Signaling Caused
by the Absence of Smad2/3 Disturbs Embry-
onic Patterning
(A) Heatmap showing the log2FC in expression of
selected Bmp target genes and those involved
in DNA methylation for Smad2/3 DKO ESCs,
EpiLCs, and day 3 EBs compared to WT controls
(n = 3 or 4).
(B) Western blot analysis of WT and Smad2/3
DKO day 3 EBs treated with DMSO or LDN-
193189 (250 nM, 24 hr from day 2 to day 3) or
untreated. Blots were probed with the indicated
antibodies.
(C and D) Anti-p-Smad1/5/8 and Oct4 (C) or
Eomes and Otx2 (D) immunofluorescence staining
of E5.5 WT or Smad2/3 DKO mouse embryos.
(E) Heatmap showing the log2FC in expression of
the top 20 upregulated genes (p < 0.05, fold
change > 1.5) in Smad2/3 DKO day 3 EBs
compared to WT day 3 EBs and their expression
changes in Smad2 KO and Smad3 KO day 3 EBs
(n = 4, averaged). See also Table S1.WT cultures (Figures 3E and S3E). In Smad2/3 DKO NPCs, the
proportion of Sox1+ cells is markedly reduced, but not elimi-
nated. Similarly, expression of the neural marker Six3 was ab-
sent from BMP4-treated NPCs and significantly reduced in
Smad2/3 DKO NPCs (Figure S3E). Moreover, Smad2/3 DKO
NPCs exhibited ectopic expression of AP2g and the epithelial
marker Krt18, normally present only in BMP4-treated WT cul-
tures (Figures 3E and S3E). Thus, neural fate appears to be
induced in a subpopulation of Smad2/3 DKO cells. However,
terminal differentiation of neuroectodermal cells is compro-
mised, possibly due to increased Bmp signaling. Thus, as re-
ported for Alk4/5/7 inhibitor-treated ectoderm explants (Li
et al., 2013), here we found that combinatorial Smad2/3 activ-
ities are required for fine-tuning the balance of neural versus
epidermal cell fates.
Ectopic Activation of Extra-Embryonic Gene Expression
in Smad2/3-Deficient EBs
Expression of Bmp target genes (Id1–Id4) was upregulated in
Smad2/3 DKO compared to WT ESCs, EpiLCs, and day 3 EBs,
consistent with increased levels of Bmp signaling activities
(Figure 4A). To examine this possibility, we differentiated
Smad2/3 DKO EBs in the presence and absence of the Bmp
type 1 receptor inhibitor LDN-193189. In contrast to WT EBs,
in which Bmp receptor inhibition markedly reduced p-S1/5/8
levels, we found that Smad2/3 DKO EBs are refractory to LDN-
193189 treatment, with levels of p-S1/5/8 and Id1 remaining un-1982 Cell Reports 24, 1977–1985, August 21, 2018changed (Figure 4B). Next, we evaluated
possibly elevated Bmp signaling in em-
bryonic day 5.5 (E5.5) double-mutant em-
bryos. InWT embryos p-S1/5/8 staining is
restricted to the proximal VE, while in
mutant embryos ectopic nuclear p-S1/5/
8 staining is present throughout the VE
(Figure 4C). Consistent with this, in dou-
ble-mutant embryos VE specification isdisrupted, as seen by loss of both Eomes and Otx2 expression
(Figure 4D).
Bmp signaling has been shown to activate extra-embryonic
gene expression (Hayashi et al., 2010). Similarly, in Smad2/3
DKO day 3 EBs, a subset of trophectoderm-derived, extra-em-
bryonic tissue-expressed genes (e.g., Plac1, Rhox6, Rhox9,
and Ascl2) and VE genes (e.g., H19) shows strongly upregulated
expression (Figure 4E). However, expression of other essential
extra-embryonic genes (e.g., Elf5) was unaffected. Thus, we
conclude that Smad2/3-deficient cells are not simply defaulting
to defined extra-embryonic fates.
Embryonic and extra-embryonic tissues in the early post-
implantation mouse embryo show distinct patterns of DNA
methylation (Smith et al., 2017). In addition, in the epiblast,
DNA methylation gradually increases, coincident with the exit
from naive pluripotency (Auclair et al., 2014; Kalkan et al.,
2017). Reduced DNA methylation has been shown to cause dis-
turbances, affecting themaintenance of embryonic and/or extra-
embryonic cell identity and ESC differentiation (Jackson et al.,
2004; Ng et al., 2008; Sakaue et al., 2010). Reduced Bmp
signaling in Smad1/5 DKO ESCs results in increased Dnmt3b
levels, enhancedDNAmethylation, andmore efficient embryonic
differentiation (Gomes Fernandes et al., 2016). Consistent with
enhanced Bmp signaling, we found that Smad2/3 DKO
day 3 EBs display decreased Dnmt3b expression and increased
expression of genes associated with DNA demethylation
(Tet2 and Gadd45b) (Figure 4A). Extra-embryonically expressed
imprinted genes (e.g., Rhox5, H19, Igf2, Ascl2, and Peg10),
whose differential expression is controlled by DNA methylation,
were also upregulated (Table S1). It is tempting to speculate
that ectopic extra-embryonic gene expression in Smad2/3-defi-
cient EBs reflects enhanced Bmp signaling, together with
changes affecting the patterns of DNA methylation.
DISCUSSION
We reported many years ago that double Smad2/3 homozygous
mutant embryos abruptly arrest at early post-implantation
stages (Dunn et al., 2004). However, it has proved difficult to
characterize the underlying molecular defects responsible for
this early lethality. Here we generated double Smad2/3 homozy-
gous null ESCs and investigated their differentiation capabilities.
Our genome-wide transcriptional profiling experiments demon-
strate that Smad2/3 activities in early epiblast cells are required
to promote the transition from naive pluripotency to lineage prim-
ing and the onset of cell fate allocation.
Our ATAC-seq analysis of Smad2/3 DKO EpiLCs revealed
changes in chromatin accessibility at distal regulatory elements
occupied by the pioneer transcription factor Oct4 and its interac-
tion partner Otx2 (Buecker et al., 2014; King and Klose, 2017).
These changes were closely associated with expression
changes at nearby genes. Oct4 interactions with Smad2/3
were previously described in naive and primed cells (Mullen
et al., 2011; Sun et al., 2014). It has been proposed that
Smad2/3 facilitates accessibility at Oct4-dependent enhancer
sites through interactions with chromatin modifiers and remodel-
ers (Funa et al., 2015; Ruetz et al., 2017). The present experi-
ments support the idea that Smad2/3/Oct4/Otx2 transcription
complexes are required tomediate cellular transitions from naive
to primed and primed to differentiated states. It will be interesting
to learn more about associations with additional cofactors hav-
ing an impact on chromatin structure and transcriptional output
at specific target loci.
Early epiblast cells normally undergo lineage priming in the
context of tightly balanced reciprocal Nodal/Smad2 and
Bmp/Smad1 signaling cues between the embryonic and the
extra-embryonic tissues (Ben-Haim et al., 2006; Yamamoto
et al., 2009). The present experiments demonstrate that
Smad2/3 inactivation results in upregulated Bmp target and ex-
tra-embryonic gene expression. Similarly, in Smad2/3 double-
mutant embryos, we find ectopic Bmp signaling throughout
the distal VE. Studies also suggest that Bmp signaling pro-
motes DNA hypo-methylation in ESCs (Gomes Fernandes
et al., 2016). It is tempting to speculate that Smad2/3 activ-
ities normally antagonize Bmp signaling and promote DNA
methylation selectively in the early epiblast to maintain its
developmental potential and prevent contributions to the
extra-embryonic cell lineages.
Smad2/3 DKO embryos are more severely disturbed and die
earlier in comparison with Nodal KO embryos (Brennan et al.,
2001; Dunn et al., 2004). Similarly, Smad2/3 DKO ESCs display
more striking differentiation defects compared with Nodal KO
ESCs. For example, Nodal KO embryos and ESCs induced to
differentiate have been shown to prematurely activate neural
gene expression (Camus et al., 2006; Mulas et al., 2017).In contrast, we found that Smad2/3 DKO ESCs induced to
differentiate display reduced neural and enhanced surface ecto-
derm-like and extra-embryonic gene expression. The simplest
explanation is that in the absence of Nodal, closely related
Smad2/3-dependent TGF-b family members like Gdf1 and
Gdf3 partially compensate (Andersson et al., 2007). Consistent
with this possibility, Nodal-deficient blastocysts have the ability
to activate the Smad2/3-dependent Nodal anterior streak
enhancer (Granier et al., 2011). Moreover, unlike Smad2/3 DKO
ESCs, Nodal KO ESCs efficiently contribute to embryonic cell
lineages (Conlon et al., 1991). Widespread tissue defects
observed in Smad2/3 DKO embryos are also considerably
more severe compared with those reported for mutant embryos
lacking Fgf5, Oct6, or Otx2 (Ang et al., 1996; Bermingham et al.,
1996; He´bert et al., 1994). Thus, it appears that the profound
developmental block in Smad2/3 DKO embryos reflects not
only defective lineage priming and embryonic cell fate allocation
but also additional disturbances caused by de-repressed Bmp
target gene and ectopic extra-embryonic gene expression.
Overall, our experiments demonstrate that combinatorial
Smad2/3 functional activities collaboratively maintain distinct
embryonic and/or extra-embryonic cell identities and strictly
divergent lineage-specific transcriptional programs in the early
mouse embryo.STAR+METHODS
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Critical Commercial Assays
Alkaline Phosphatase Detection Kit Millipore Cat#SCR004
Nextera DNA Library Preparation Kit Illumina Cat#FC-121-1030
Deposited Data
RNA-seq on Smad2/3 DKO and control epiblast-
like cells
N/A GEO: GSE110163, Table S2, Series
GSE110164
ATAC-seq on Smad2/3 DKO and control
epiblast-like cells (including Tn5 control)
N/A GEO: GSE110162, Table S3, Series
GSE110164
Illumina MouseWG-6 v2.0 Expression BeadChip
microarray on Smad2/3 DKO, Smad2 KO,
Smad3 KO and WT mouse ESCs, d2 and d3 EBs
N/A GEO: GSE110058, Table S1, Series
GSE110164
Experimental Models: Cell Lines
WT CCE 129/Sv//Ev embryonic stem cells (Robertson et al., 1986) N/A
Smad2tm1Rob/tm1Rob 129/Sv//Ev embryonic stem cells (Tremblay et al., 2000) N/A
Smad3tm1Xfw/tm1Xfw 129/Sv * C57BL/6 embryonic stem
cells
This study N/A
Smad3CRISPR/CRISPR 129/Sv//Ev embryonic stem cells This study N/A
Smad2tm1Rob/tm1Rob;Smad3CRISPR/CRISPR 129/Sv//Ev
embryonic stem cells
This study N/A
NIH 3T3 cells ATCC RRID: CVCL_0594
Experimental Models: Organisms/Strains
Mouse: Smad3tm1Xfw/+: C57BL/6 Obtained from (Datto et al.,
1999)
RRID: MGI:2182651
Mouse: Smad2tm1Rob/+: C57BL/6 (Waldrip et al., 1998) MGI:1857691
Oligonucleotides
Smad3 CRISPR_50 nick 1 forward CACCGCCCACG
TGGGCCACCGGGTAGGG
This study N/A
Smad3 CRISPR_50 nick 1 reverse AAACTACCCGGT
GGCCCACGTGGGC
This study N/A
(Continued on next page)
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Smad3 CRISPR_50 nick 2 forward CACCGCGCTG
GCGGCGCTGGGCGGGG
This study N/A
Smad3 CRISPR_50 nick 2 reverse AAACCGCCCA
GCGCCGCCAAGCGC
This study N/A
Smad3 CRISPR_30 nick 1 forward CACCGTGTCCC
GCCCCACTCGAAGCGC
This study N/A
Smad3 CRISPR_30 nick 1 reverse AAACCCGCTT
CGAGTGGGGCGGGACAC
This study N/A
Smad3 CRISPR_30 nick 2 forward CACCGTCAGTA
CATTCTGTCAGATCTGG
This study N/A
Smad3 CRISPR_30 nick 2 reverse AAACCCAGAT
CTGACAGAATGTACTGAC
This study N/A
CRISPR_U6 sequencing primer forward GACTATCAT
ATGCTTACCGT
This study N/A
Primers for qRT-PCR and OneStep RT-PCR
analysis as well as mouse genotyping and
Southern blot probe, see Table S4
This study N/A
Recombinant DNA
pSpCas9n(BB)-2A-GFP (PX461) (Ran et al., 2013) Addgene Plamid #18140
Software and Algorithms
CRISPR design tool (Hsu et al., 2013) http://crispr.mit.edu
Bowtie2 aligner (Langmead and
Salzberg, 2012)
http://bowtie-bio.sourceforge.net/
bowtie2/index.shtml
STAR aligner (Dobin et al., 2013) https://github.com/alexdobin/STAR
Samtools (Li et al., 2009) http://samtools.sourceforge.net/
Danpos2 (Chen et al., 2013) https://sites.google.com/site/
danposdoc/
MACS2 (Zhang et al., 2008) https://github.com/taoliu/MACS
bedtools (Quinlan and Hall, 2010) http://bedtools.readthedocs.io/
en/latest/#
UCSC Genome Browser https://genome.ucsc.edu/
DiffBind R package (Ross-Innes et al., 2012) https://bioconductor.org/packages/
release/bioc/html/DiffBind.html
DESeq2 R package (Love et al., 2014) http://bioconductor.org/packages/
release/bioc/html/DESeq2.html
HOMER (Heinz et al., 2010) http://homer.ucsd.edu/homer/
index.html
JavaTreeView (Saldanha, 2004) http://jtreeview.sourceforge.net/
Analysis of Motif Enrichment Feature in the
MEME suite
(McLeay and Bailey, 2010) http://meme-suite.org/doc/
ame.html?man_type=web
GREAT (McLean et al., 2010) http://bejerano.stanford.edu/great/
public/html/
Arrayanalysis (Eijssen et al., 2015) http://www.arrayanalysis.org/
BioVenn (Hulsen et al., 2008) http://www.biovenn.nl/
Fiji (Schindelin et al., 2012) https://imagej.net/Fiji
Other
Mus musculus rRNA genomic sequence GenBank BK000964.3
mm10 genome UCSC Genome Browser http://hgdownload.cse.ucsc.edu/
goldenPath/mm10/bigZips/
Sequencing data from Oct4, Otx2, p300,
H3K4me1 and H3K27ac ChIP-seq in EpiLCs
and RNA-seq in mouse ESCs and EpiLCs
(Buecker et al., 2014) GSE56138
(Continued on next page)
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Sequencing data from Smad2/3 ChIP-seq in
mouse ESCs and embryoid bodies treated
with Activin A or SB-431242
(Wang et al., 2017) GSE70486
Sequencing data from ATAC-seq in mouse
ESCs and in vitro differentiated definitive
endoderm
(Simon et al., 2017) GSE94250
Sequencing data from Smad1 ChIP-seq in
mouse ESCs treated with BMP4
(Morikawa et al., 2016) GSE70581CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Elizabeth
Robertson (elizabeth.robertson@path.ox.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal care and use
E5.5 Smad2/3 DKO embryos were obtained from intercrosses of Smad3tm1Xfw/+;Smad2tm1Rob/+ (Waldrip et al., 1998; Datto et al.,
1999) animals. Blastocysts for ESC derivation and thymus tissue for protein lysates were obtained from the Smad3tm1Xfw C57BL/6
mouse strain (Datto et al., 1999). PCR genotyping primers are listed in Table S4. All animal experiments were performed in accor-
dance with Home Office (UK) regulations and approved by the University of Oxford Local Ethical Committee.
ESC culture
All ESC lines used were XY and grown in feeder-free conditions on 0.1% gelatin-coated dishes at 6% CO2 at 37
C. ESCs were
cultured in DMEM (GIBCO, Cat#11960-085) supplemented with 15% FBS (GIBCO Cat#10500-062, Lot: 07Q3446K), 1% PEN/
STREP, 1% glutamine, 1% NEAA, 1mM sodium pyruvate, 100 mM b-mercaptoethanol and 1000 U/ml LIF (SL). Alternatively, ESCs
were cultured in serum-free media containing N2B27 (NDiff227, Cat#Y40002) supplemented with 1 mM PD0325091 and 3 mM
CHIR99021 and 1000 U/ml LIF (2iL).
METHOD DETAILS
Generation of knockout lines
Smad3 KO and Smad2/3 DKO ESC lines
Two sets of four sgRNAs flanking exon 1 of murine Smad3 were designed using the Zhang lab CRISPR design tool (Hsu et al., 2013)
taking care to avoid T-rich 30 ends and to keep off-sets between nickase-sgRNAs < 10 bp. The PAMsequencewas removed andBbsI
sites engineered at the ends. After cloning into pSpCas9n(BB)-2A-GFP (PX461) (Ran et al., 2013) constructs were transfected into
Stbl3 cells. Efficiency of sgRNA plasmids was confirmed by high resolution melt analysis. A maximum of 5 mg pooled isolated
non-linearized plasmid DNAs (QIAGEN Maxi Prep kit, Cat#12663) was transfected into 1 3 106 ESCs (either 129/Sv//Ev CCE WT
(Robertson et al., 1986) or Smad2tm1Rob/tm1Rob (Tremblay et al., 2000)) using the Neon transfection system (Thermo Fisher Scien-
tific, Cat#MPK5000) followed by low-density plating. Deletion of exon 1was screened for by Southern blotting using aXbaI digest and
a probe 30 to the deletion (for sequences see Table S4). Loss of Smad3 protein was confirmed by western blotting using specific
antibodies (see Key Resources Table).
Conventional Smad3/ control lines
To generate Smad3/ ESCs, blastocysts were obtained fromSmad3tm1Xfw/+ femalesmated to Smad3tm1Xfw/+ males. ESC lines were
isolated in 2iL as previously described (Ying et al., 2008). Homozygous lines were identified by PCR using the genotyping primers
listed in Table S4.
EpiLC induction
EpiLCs were induced from ESCs (2iL) as previously described (Hayashi et al., 2011). In brief, 2.33 3 105 cells were washed and re-
suspended in N2B27 medium (Takara, Cat#Y40002) supplemented with 12ng/ml Fgf2, 20ng/ml Activin A and 1% KSR (GIBCO,
Cat#10828, Lot:1508151) and grown on fibronectin-coated (5 mg/cm2) 6cm dishes. Medium was exchanged daily and cells grown
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PGCLC induction
PGCLCs were induced from d2 EpiLCs as described previously (Hayashi and Saitou, 2013). In brief, 2000 cells were washed and
plated into lipidure-coated U-bottom shaped 96-well plates in serum-free medium (GK15; GMEM (Invitrogen) with 15% KSR,
0.1 mM NEAA, 1 mM sodium pyruvate, 0.1 mM 2-mercaptoethanol, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2 mM
L-glutamine) in the presence of the cytokines BMP4 (500 ng/ml; R&D Systems), LIF (1000 u/ml; Invitrogen), SCF (100 ng/ml; R&D
Systems), BMP8b (500 ng/ml; R&D Systems), and EGF (50 ng/ml; R&D Systems).
EB differentiation
ESCs (SL) were trypsinized, resuspended in serum-containing medium without LIF (EB medium), pelleted, washed in PBS (w/o
MgCl2) and counted. A single-cell solution of 13 10
4 cells/ml in EB medium was pipetted into 10 mL drops onto square 12cm plates
and inverted to generate hanging drops. After 48 h the resultant EBs were harvested and either collected (d2 EB) or kept in suspen-
sion for further 24h (d3 EB) or 48h (d4 EB). For LDN-193189 treatment, d2 EBs were harvested as above after 48h and plated in EB
medium containing LDN-193189 (250nM; Stemgent) or equal amounts of DMSO carrier for 24h. As controls, serum-starved NIH 3T3
cells were treated with Bmp4 (50ng/ml) for 30min (or left untreated).
NPC induction
ESCs (SL) were trypsinized when 70%–80% confluent and washed twice in N2B27. 13 104 cells/cm2 were plated in N2B27medium
on fibronectin-coated (5 mg/cm2) dishes. Medium was changed on the second day of differentiation and then daily.
ATAC-seq
Tagmentation and indexing of single cell suspensions (75,000 cells in technical duplicates) of three independent differentiation of
Smad2/3 DKO or WT EpiLCs was performed as previously described (Buenrostro et al., 2013). To control for sequence bias of
the Tn5 transposase, 100ng genomic DNA of WT EpiLCs was also tagmented and indexed. Samples were sequenced using a
75-cycle paired end Nextera kit with custom Nextera index primers Ad2.1-2.13 taken from Table S1 in Buenrostro et al. (2013) on
the Illumina HiSeq4000 platform.
Microarray profiling
d2 and d3 EBs were harvested, washed and total RNA isolated (QIAGEN RNAeasy micro kit, Cat# 74004). Four independent clones
were used per genotype. Undifferentiated cells were collected prior to EB set-up. Biotinylated cRNA (1.5 mg RNA per sample) was
randomly hybridized to Illumina MouseWG-6 v2.0 Expression BeadChip microarrays.
RNA-seq
RNA was isolated from 1.5 x106 Smad2/3 DKO and WT EpiLCs from three independent EpiLC differentiations per genotype, using
samples taken from the same cells used for ATAC-seq (QIAGEN RNeasy mini kit, Cat#74104). Total RNA was normalized to 800ng
per sample, depleted of cytoplasmic and mitochondrial ribosomal RNA sequences (Ribo-Zero Gold rRNA Removal Kit (H/M/R),
Cat: #MRZG12324) and used for library preparation using the Illumina TruSeq Stranded Total RNA Library Prep (H/M/R)
(Cat: #20020597), followed by sequencing (75-cycle paired end) on the Illumina HiSeq4000 platform.
RT-PCR
1 mg RNA was reverse transcribed to cDNA using Superscript III First Strand Synthesis System (Life Technologies, Cat#18080-051)
and diluted to 160 mL final volume in H2O. 2 mL were used per qRT-PCR reaction in duplicate using SYBR-green kit (QIAGEN,
Cat#204143). Relative gene expression was normalized to Gapdh expression and calculated as 2DDCt. OneStep RT-PCR analysis
was performed on 50ng RNA using OneStep RT-PCR kit (QIAGEN, Cat#210210) following the manufacturers protocols. Samples
were run on 2% agarose/1xTAE gels. qRT-PCR and OneStep RT-PCR primer sequences are listed in Table S4.
Immunofluorescence
ESCs or EpiLCs grown in 8-well chamber slideswerewashed twice in PBS (withMgCl2) and fixed in 4%PFA (10min at RT). After three
further washes, cells were permeabilized in PBS plus 0.2% Triton X-100, followed by two washes in PBS plus 0.05% Tween-20
(PBST) then blocked (10% donkey serum and 1% BSA in PBST for 1h at RT) and incubated with primary antibodies in blocking
solution (see above) (o/n at 4C). Following two washes in PBST, cells were incubated with fluorescence-labeled secondary anti-
bodies in blocking solution for 1h at RT followed by two washes in PBST containing 2 mg/ml DAPI prior to mounting in Vectashield
with DAPI (H-1200) and imaging on a Leica epifluorescence microscope. d2 and d3 EBs, d2 and d4 PGCLCs and E5.5 mouse
embryos were harvested, washed in PBS (with MgCl2), fixed in 1%PFA o/n at 4
C. After three washes in PBS containing 0.1% Triton
X-100 (PBSTr), samples were permeabilized in PBS containing 0.5% Triton X-100 followed by three washes in PBSTr then blocked
(5% donkey serum and 0.2% BSA in PBSTr for 1h at RT) and incubated with primary antibodies in blocking solution (o/n 4C).
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(2h, RT) followed by three washes in PBSTr, one wash in PBSTr containing 2 mg/ml DAPI and three washes in PBSTr prior tomounting
in Vectashield with DAPI (H-1200). Samples were imaged the following day on an Olympus Fluoview FV1000 confocal microscope.
Antibodies are listed in the Key Resources Table.
Colony forming assay
675 single ESCs (SL) of three independent clones per genotype were seeded on gelatin coated 6cm dishes and fed daily. On day
7 colonies were washed with PBS, fixed with 70% ethanol (10min, room temperature) stained with Giemsa stain (GIBCO) for
15min at RT, washed extensively with tap water and air-dried. Colony area surface was measured at day 5 of colony formation using
Fiji (Schindelin et al., 2012).
Alkaline phosphatase staining
600 single ESCs (SL) from three independent clones per genotype were seeded. The following day, medium was exchanged to
medium without or with LIF and replaced daily. On d5 cells were washed in PBS, fixed in 4% PFA (1min at RT), washed in TBST,
stained with alkaline phosphatase staining solution (Millipore, Cat#SCR004) for 15 min at RT, washed in TBST and imaged. Differ-
entiated, mixed and undifferentiated colonies were scored and counted.
QUANTIFICATION AND STATISTICAL ANALYSIS
RT-PCR
Statistical significance between Smad2/3 DKO andWT samples was determined using the R function wilcox.test with default param-
eters. Significance levels are denoted by * for p < 0.05 and ** for p < 0.01.
Microarray analysis
Bead-Station data were extracted using the Gene Expression Analysis Module V1.6.0 of GenomeStudio V2009.2 (Illumina)
and imported into an R-based Illumina pre-processing module (Eijssen et al., 2015). Hierarchical clustering identified three outlier
samples in ESCs that were excluded from subsequent analysis. Differential probe expression was determined using an R-based
statistical analysis module (Eijssen et al., 2015) with raw p values compared to averaged WT signal at the same time-point. Unique
ILMN_GENE gene identifiers of probes with significantly different expression (p < 0.05 and fold change > 1.5) were identified
and were analyzed using Venn diagram overlaps (Hulsen et al., 2008). For WT top expressed genes, d3 EB datasets
were compared to averaged ESC datasets. Heatmaps of log2FC values for individual clones were made using Java TreeView
(Saldanha, 2004).
ATAC-seq, ChIP-seq and RNA-seq analysis
Paired-end reads for ATAC-seq and ChIP-seq were aligned to the mouse mm10 genome using bowtie2 (Langmead and Salzberg,
2012) with the ‘‘–no-mixed’’ and ‘‘–no-discordant’’ options. Non-uniquely mapping reads and reads mapping to a custom ‘‘blacklist’’
of artificially high regions of the genome were discarded. For RNA-seq, reads were initially aligned using bowtie2 against the rRNA
genomic sequence (GenBank: BK000964.3) to filter out rRNA fragments, prior to alignment against the mm10 genome using the
STAR RNA-seq aligner with default parameters (Dobin et al., 2013) PCR duplicates were removed using Samtools (Li et al., 2009).
Biological replicates were randomly downsampled to contain the same number of reads for each individual replicate, and merged
to create a representative genome track using DANPOS2 (Chen et al., 2013) for ATAC-seq samples and MACS2 (Zhang et al.,
2008) for ChIP-seq and genomecov from bedtools (Quinlan and Hall, 2010) for RNA-seq. Genome coverage tracks were visualized
using the UCSC Genome Browser.
ATAC hypersensitive sites in bothWT and SMAD2/3 null EpiLCs were identified using the DANPOS2 dpeak function with biological
triplicates and a Tn5 genomic DNA control. Significant changes in ATAC-seq datasets were identified using the DiffBind package
(Stark and Brown, 2011). For RNA-seq, the mm10 refGene gene bodies were annotated with biological replicate read counts and
gene expression changes were identified with DESeq2 (Love et al., 2014). For both DiffBind and DESeq2, a FDR < 0.05 and a fold
change > 1.5 was deemed a significant change. To link differential gene expression with Smad2/3 ChIP-seq signal in ESCs and
EBs (Wang et al., 2017), we called Smad2/3 peaks using DANPOS2, annotated peaks with the closest RefSeq TSS using HOMER
(Heinz et al., 2010) and excluded peaks > 50kb away from RefSeq TSSs.
Changes in ATAC-seq were visualized using heatmaps produced using HOMER and Java TreeView. GREAT was used to iden-
tify the distance of peaks to known TSS (McLean et al., 2010). To identify accessibility changes during the ESC to EpiLC transition,
we used ATAC-seq data from Simon et al. (2017) with DiffBind as above. To compare differential chromatin accessibility with
changes in nearby gene expression, we used HOMER to identify the transcriptional start sites (TSS) nearest to sites with differ-
ential chromatin accessibility and visualized the log2FC gene expression changes in RNA-seq data from Smad2/3 DKO EpiLCs in
comparison to WT EpiLCs as a heatmap. Differentially accessible sites in Smad2/3 DKO EpiLCs were annotated with published
p300, H3K27ac, H3K4me1, Smad2/3, Smad1, Oct4 and Otx2 ChIP-seq data (Buecker et al., 2014; Morikawa et al., 2016; WangCell Reports 24, 1977–1985.e1–e7, August 21, 2018 e6
et al., 2017). Enrichment of transcription factor motifs in differentially accessible ATAC-seq peaks was performed using the
Analysis of Motif Enrichment (AME) feature in the MEME suite (McLeay and Bailey, 2010) with a background control of unaffected
ATAC-seq peaks.
DATA AND SOFTWARE AVAILABILITY
The accession number for the data reported in this paper is GEO: GSE110164 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
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